Li et al. found that knocking out CTSB inhibits cell proliferation in the human cholangiocarcinoma cell line QBC939 [46], and mice lacking CTSB had reduced cell proliferation in mammary carcinomas and their lung metastases. Here, CTSB is linked to breast carcinoma.